ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NFL Running Back Nyheim Hines Supports Nation's Largest St. Patrick’s Day Fundraising Campaign to Benefit Muscular Dystrophy Association

New York, March 13, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced its continued partnership with Nyheim Hines -- an NFL running back who has agreed to a new contract to play for the Cleveland Browns -- to serve as the 2024 MDA National Spokesperson, heading into the nation's largest St. Patrick's Day fundraising campaign, MDA Shamrocks. The campaign includes thousands of retail locations across the country raising funds to empower the lives of children and adults living with muscular dystrophy, ALS (also known as Lou Gehrig’s disease), and related neuromuscular diseases to benefit the organization's mission. Hines proudly wears the 2024 limited edition MDA Shamrocks t-shirt designed by MDA Board member Matthew Plummer who lives with neuromuscular disease. People donating $35 or more will receive the limited-edition t-shirt. Donations may be made at MDA.org/Shamrocks2024. Funds raised go towards accelerating research, advancing care, and advocating for the support of families who live with a neuromuscular disease. 

With family members who live or have lived with muscular dystrophy, Hines continues to generate awareness and raise critical funds for the neuromuscular disease community.

"It's truly humbling to continue to raise awareness for the neuromuscular disease community through the mission of Muscular Dystrophy Association. The MDA Shamrocks campaign is iconic and I’m proud to be part of this campaign raising funds to support research, care, and advocacy for the organization and to continue in my role as the 2024 MDA National Spokesperson," stated Nyheim Hines, NFL Running Back. "This cause holds profound significance for my family. Witnessing my mother's journey with limb-girdle muscular dystrophy reinforces the importance of the MDA's community, offering invaluable support and fostering hope for advancements in treatment, enhanced care, and a more promising tomorrow. When we raise our voices together, lives are transformed. Working together we can move further faster for the neuromuscular disease community.”

"For more than four decades, the MDA Shamrocks campaign has raised hundreds of millions of dollars and funded innovative research, care, and life-changing experiences such as MDA Summer Camp," said Morgan Roth, Chief Marketing Officer. “We are extremely grateful to have Nyheim Hines participating in these efforts. It’s our privilege to collaborate with Nyheim to bring the fruits of our mission to his family and millions more across the country."

MDA Public Service announcement featuring Nyheim Hines
View Platinum Marcom/AMCP award winning Public Service Announcements by MDA National Spokesperson Nyheim Hines here.

About Muscular Dystrophy Association
Muscular Dystrophy Association (MDA) is the #1 voluntary health organization in the United States for people living with muscular dystrophy, ALS, and related neuromuscular diseases. For over 70 years, MDA has led the way in accelerating research, advancing care, and advocating for the support of our families. MDA's mission is to empower the people we serve to live longer, more independent lives. To learn more visit mda.org and follow MDA on InstagramFacebookXThreadsTikTokLinkedIn, and YouTube.

Attachment


Mary Fiance, National Vice President, Strategic Communications
Muscular Dystrophy Association
press@mdausa.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.